PT - JOURNAL ARTICLE AU - Michelle Gates AU - Jennifer Pillay AU - Aireen Wingert AU - Samantha Guitard AU - Sholeh Rahman AU - Bernadette Zakher AU - Allison Gates AU - Lisa Hartling TI - Risk factors associated with severe outcomes of COVID-19: An updated rapid review to inform national guidance on vaccine prioritization in Canada AID - 10.1101/2021.04.23.21256014 DP - 2021 Jan 01 TA - medRxiv PG - 2021.04.23.21256014 4099 - http://medrxiv.org/content/early/2021/04/26/2021.04.23.21256014.short 4100 - http://medrxiv.org/content/early/2021/04/26/2021.04.23.21256014.full AB - Background To inform vaccine prioritization guidance by the National Advisory Committee on Immunization (NACI), we reviewed evidence on the magnitude of association between risk factors and severe outcomes of COVID-19.Methods We updated our existing review by searching online databases and websites for cohort studies providing multivariate adjusted associations. One author screened studies and extracted data. Two authors estimated the magnitude of association between exposures and outcomes as little-to-no (odds, risk, or hazard ratio <2.0, or >0.50 for reduction), large (2.0-3.9, or 0.50-0.26 for reduction), or very large (≥4.0, or ≤0.25 for reduction), and rated the evidence certainty using GRADE.Results Of 7,819 unique records we included 111 reports. There is probably (moderate certainty) at least a large increase in mortality from COVID-19 among people aged 60-69 vs. <60 years (11 studies, n=517,217), with ≥2 vs. no comorbidities (4 studies, n=189,608), and for people with (vs. without): Down syndrome (1 study, n>8 million), type 1 and 2 diabetes (1 study, n>8 million), end-stage kidney disease (1 study, n>8 million), epilepsy (1 study, n>8 million), motor neuron disease, multiple sclerosis, myasthenia gravis, or Huntington’s disease (as a grouping; 1 study, n>8 million). The magnitude of association with mortality is probably very large for Down syndrome and may (low certainty) be very large for age 60-69 years, and diabetes. There is probably little-to-no increase in severe outcomes with several cardiovascular and respiratory conditions, and for adult males vs. females.Interpretation Future research should focus on risk factors where evidence is low quality (e.g., social factors) or non-existent (e.g., rare conditions), the pediatric population, combinations of comorbidities that may increase risk, and long-term outcomes.Systematic review registration PROSPERO #CRD42021230185.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was completed under contract to the Public Health Agency of Canada, contract #4600001536. LH is supported by a Tier 1 Canada Research Chair in knowledge synthesis and translation. The funders had no role in the conduct of the study nor decision to submit for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics approval was not required because this is a systematic review.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data pertaining to the conclusions are available on reasonable request using the following link: https://doi.org/10.7939/DVN/VDELOG. https://doi.org/10.7939/DVN/VDELOG